Deliargyris Efthymios Insider Trades

Insider Trading History

Track insider trading activity for Deliargyris Efthymios. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $231k 473,025 shares
Last Trade
Aug 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95k 95,000 shares
$1.00
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 17, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$16.2k 16,233 shares
$1.00
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $7.92k 16,233 shares
Last Trade
Jan 17, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$33.4k 32,466 shares
$1.03
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $197k 403,025 shares
Last Trade
Jan 17, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$16.2k 16,233 shares
$1.00
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $48.8k 100,000 shares
Last Trade
Oct 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 150,000 shares
$1.19
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $200k 409,433 shares
Last Trade
Apr 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.6k 86,000 shares
$0.96
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $23k 47,088 shares
Last Trade
Mar 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 47,088 shares
$0.95
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $170k 348,433 shares
Last Trade
Dec 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.3k 30,451 shares
$1.75
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $162k 331,648 shares
Last Trade
Jul 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$611k 173,000 shares
$3.53
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $146k 300,000 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$585k 300,000 shares
$1.95
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $89.3k 183,000 shares
Last Trade
Apr 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$928k 103,250 shares
$8.99
$0.49
Cytosorbents
Cytosorbents CTSO
Chief Medical Officer
Holding Value $68.3k 140,000 shares
Last Trade
Apr 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49M 225,500 shares
$6.59
$0.49
PLx Pharma
PLx Pharma PLXP
Chief Medical Officer
Holding Value $5.22k 60,000 shares
Last Trade
Mar 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 60,000 shares
$2.16
$0.09
PLx Pharma
PLx Pharma PLXP
Chief Medical Officer
Holding Value $5.22k 60,000 shares
Last Trade
Mar 14, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$347k 60,000 shares
$5.79
$0.09
PLx Pharma
PLx Pharma PLXP
Chief Medical Officer
Holding Value $6.09k 70,000 shares
Last Trade
Aug 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$223k 70,000 shares
$3.18
$0.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up